We are pleased to share that last month Corticalis received the ISO13485:2016 certification.
This important milestone confirms that our quality management system meets the internationally recognized standards specific to the design, development, and production of medical devices.
Corticalis AS was proud to participate in EuroPerio11 in Vienna in 2025 — the world’s leading congress in periodontology and implant dentistry. The event brought together clinicians, researchers, and industry leaders from across the globe, offering a unique platform for knowledge exchange, technology demonstration, and strategic collaboration.
🔬 Corticalis AS is proud to contribute as an associated partner in two Horizon Europe Marie Skłodowska-Curie Doctoral Training Networks
Both initiatives build on our ongoing Norges forskningsråd-funded DEBRIGEL project and reflect growing recognition of our commitment to advancing peri-mucositis and peri-implantitis care through innovation.
Last week, our CEO Ståle Petter Lyngstadaas and our Chairman of the Board Jan Eirik Ellingsen attended IDS in Cologne, where they had the opportunity to meet with René Willi, CEO of medmix AG. René joined the Corticalis Board a few months ago, and we are excited to have his extensive expertise as we continue to grow.
This month, Angela De Lauretis had the opportunity to attend the 2025 AADOCR/CADR Annual Meeting & Exhibition in New York, where she presented her Industrial PhD work with Corticalis on chemical debridement products.
Angela De Lauretis captivated the audience with her presentation on our novel strategies for managing peri-mucositis and peri-implantitis. She addresses a common and complex clinical challenge with innovative solutions by combining effective implant debridement techniques with approaches to restore peri-health.
On October 30th, 2024, Corticalis participated in a highly engaging seminar focused on biomaterial-associated infections, drawing a large audience of students and faculty members. The event featured international peri-implantitis experts Mariano Sanz, Lisa Heitz-Mayfield, and Mario Romandini, who shared their extensive research on the definitions, diagnostics, and cutting-edge interventions related to peri-implant diseases.
On October 27th, 2024, our first Clinical Advisory Board meeting took place in Holmenkollen, Oslo. This meeting brought together leading international experts in implant care and peri-implant health, including Mariano Sanz, Morten Klepp, Lisa Heitz-Mayfield, Leonardo Trombelli, and Fritz Heitz-Mayfield, along with the Corticalis AS team — Ståle Petter Lyngstadaas, Jan Eirik Ellingsen, Håvard Jostein Haugen, and Angela De Lauretis.
The meeting provided valuable insights, leading to several immediate improvements and establishing a clear path for future developments.
We are delighted to announce that our industrial PhD student, Angela De Lauretis, presented her groundbreaking work at the prestigious EAO (European Association for Osseointegration) conference in Milan.
Corticalis AS is proud to announce that Ingvild Nysæther has received the award for Best “Clinical Innovations in Implant Dentistry” at the EAO (European Association for Osseointegration) conference in Milan. This recognition was granted for the first clinical trial on our bone graft material, NuBone® Augment.
We’re delighted to announce that Minh has successfully defended his thesis, “The dynamics of bone augmentation with a TiO₂ graft material: Studies in challenging pre-clinical models.” His work focuses on our ceramic titanium dioxide scaffolds, which offer safer, more adaptable bone graft solutions for dental and orthopaedic treatments.